Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakub Hort

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Neurology|September 29, 2020
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Nature Aging|April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's diseasePetr Novak, Branislav Kovacech, Stanislav Katina, et al.
Neurobiology of Aging|June 15, 2021
Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Zuzana Nedelska, Jonathan Graff-Radford, et al.
Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
Movement Disorders Clinical Practice|June 19, 2023
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease DementiaMaria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2023
Pathogenesis of Alzheimer's disease: Involvement of the choroid plexusMaria Čarna, Isaac G Onyango, Stanislav Katina, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohortsVeerle van Gils, Willemijn J Jansen, Wiesje M van der Flier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center studyJames D Doecke, Giovanni Bellomo, Lisa Vermunt, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Neurology|September 29, 2020
β-Amyloid and tau biomarkers and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Scott A Przybelski, Timothy G Lesnick, et al.
Nature Aging|April 28, 2023
ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer's diseasePetr Novak, Branislav Kovacech, Stanislav Katina, et al.
Neurobiology of Aging|June 15, 2021
Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodiesDaniel Ferreira, Zuzana Nedelska, Jonathan Graff-Radford, et al.
Nature Communications|January 29, 2025
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatmentKatharina Bolsewig, Eline A J Willemse, Pascual Sánchez-Juan, et al.
Movement Disorders Clinical Practice|June 19, 2023
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease DementiaMaria Camila Gonzalez, Diego Alejandro Tovar-Rios, Guido Alves, et al.
International Journal of Geriatric Psychiatry|September 8, 2020
Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer's disease consortium surveyKristian S Frederiksen, Thomas R Nielsen, Ildebrando Appollonio, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 24, 2023
Pathogenesis of Alzheimer's disease: Involvement of the choroid plexusMaria Čarna, Isaac G Onyango, Stanislav Katina, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 30, 2025
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohortsVeerle van Gils, Willemijn J Jansen, Wiesje M van der Flier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 23, 2025
Diagnostic performance of plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center studyJames D Doecke, Giovanni Bellomo, Lisa Vermunt, et al.
Pageof 19